Literature DB >> 9932265

Radical surgery and reoperation in supratentorial malignant glial tumors.

M Daneyemez1, F Gezen, Z Canakçi, S Kahraman.   

Abstract

The treatment modalities for gliomas are still questioning and searching. We reviewed the effect of the extent of surgical resection and reoperation on the length and quality of survival in 152 consecutive patients who underwent operation for supratentorial gliomas at GATA Neurosurgery clinic between 1985 to 1995. Seventy-two patients (50%) had glioblastoma multiforme (GBM), and 48 patients (33%) had anaplastic astrocytoma (AA). Gross total resection was achieved in 70 cases (49%), subtotal resection was performed in 60 cases (42%), and biopsy was carried out in 14 cases (9%). Thirty-two patients were reoperated for recurrency and the median interval between the first operation and reoperation was 9.5 months in glioblastoma multiforme, and 11.7 months in anaplastic astrocytoma. The resection groups were compared for age, sex, preoperative and postoperative Karnofsky rating, tumor location, postoperative radiation therapy, and chemotherapy, and survival according to multivariate analysis. Preoperative Karnofsky rating and surgical resection type were the most important factors related to survival after operation or reoperation. The gross total resection group lived longer than the subtotal resection group by life table analysis. Median survival of GBM was 76 weeks in gross total resection group, and 33 months in AA group with total resection (p < 0.001). Preoperative Karnofsky scores had a statistically significant effect on the quality of life and survival after operation and reoperation in all cases (p = 0.005). Radical surgery and reoperation also improve quality and length of life in selective malignant supratentorial gliomas.

Entities:  

Mesh:

Year:  1998        PMID: 9932265     DOI: 10.1055/s-2008-1052044

Source DB:  PubMed          Journal:  Minim Invasive Neurosurg        ISSN: 0946-7211


  9 in total

1.  Novel Surgical Approaches to High-Grade Gliomas.

Authors:  Fahid Tariq Rasul; Colin Watts
Journal:  Curr Treat Options Neurol       Date:  2015-09       Impact factor: 3.598

2.  Re-resection for recurrent high-grade glioma in the setting of re-irradiation: more is not always better.

Authors:  Joshua D Palmer; Joshua Siglin; Kosj Yamoah; Tu Dan; Colin E Champ; Voichita Bar-Ad; Maria Werner-Wasik; James J Evans; Lyndon Kim; Jon Glass; Christopher Farrell; David W Andrews; Wenyin Shi
Journal:  J Neurooncol       Date:  2015-05-30       Impact factor: 4.130

3.  Canadian recommendations for the treatment of recurrent or progressive glioblastoma multiforme.

Authors:  J C Easaw; W P Mason; J Perry; N Laperrière; D D Eisenstat; R Del Maestro; K Bélanger; D Fulton; D Macdonald
Journal:  Curr Oncol       Date:  2011-06       Impact factor: 3.677

Review 4.  Brachytherapy for brain tumors.

Authors:  Todd W Vitaz; Peter C Warnke; Viviane Tabar; Philip H Gutin
Journal:  J Neurooncol       Date:  2005-05       Impact factor: 4.130

5.  Rana catesbeiana ribonuclease induces cell apoptosis via the caspase-9/-3 signaling pathway in human glioblastoma DBTRG, GBM8901 and GBM8401 cell lines.

Authors:  Jen-Ni Chen; Giou-Teng Yiang; Yi-Fan Lin; Pei-Lun Chou; Tsai-Kun Wu; Wei-Jung Chang; Chinshuh Chen; Yung-Luen Yu
Journal:  Oncol Lett       Date:  2015-04-15       Impact factor: 2.967

6.  Evaluation of preoperative high magnetic field motor functional MRI (3 Tesla) in glioma patients by navigated electrocortical stimulation and postoperative outcome.

Authors:  K Roessler; M Donat; R Lanzenberger; K Novak; A Geissler; A Gartus; A R Tahamtan; D Milakara; T Czech; M Barth; E Knosp; R Beisteiner
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-08       Impact factor: 10.154

Review 7.  The role of cytoreductive surgery in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline.

Authors:  Timothy Charles Ryken; Steven N Kalkanis; John M Buatti; Jeffrey J Olson
Journal:  J Neurooncol       Date:  2014-04-23       Impact factor: 4.130

8.  Role of surgical resection in recurrent glioblastoma: prognostic factors and outcome evaluation in an observational study.

Authors:  Federico Pessina; Pierina Navarria; Luca Cozzi; Stefano Tomatis; Marco Riva; Anna Maria Ascolese; Armando Santoro; Matteo Simonelli; Lorenzo Bello; Marta Scorsetti
Journal:  J Neurooncol       Date:  2016-11-08       Impact factor: 4.130

9.  Long-term expression of rAAV2-hIL15 enhances immunoglobulin production and lymphokine-activated killer cell-mediated human glioblastoma cell death.

Authors:  Giou-Teng Yiang; Ruey-Hwang Chou; Wei-Jung Chang; Chyou-Wei Wei; Yung-Luen Yu
Journal:  Mol Clin Oncol       Date:  2013-01-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.